A "DSIR Recognized" Research Based Company
 +91 8459261119 / +91 8888803973  info@genextgenomics.com
search

Antibody engineering & library services Antibody Library Services Genext Genomics has proprietary phage display library for production of high affinity monoclonal antibodies and has been specialized in applying the technologies for wide range of service project. Read More Expression and Purification of Recombinant Proteins Recombinant Proteins Expression and Purification Cloning the gene, Sub cloning in the expression vector, Upstream- expression and purification at analytical scale; downstream process - scale up Read More Production of Monoclonal Antibodies Monoclonal Antibodies Production Cloning the gene, Sub cloning in the expression vector, Upstream- expression and purification at analytical scale; downstream process - scale up Read More Recombinant Antibody Services Recombinant Antibody Services Cloning scfv in E.Coli expression vector, Cloning of full IgG in CHO expression system Read More

“One Stop Solution – Gene to Protein to Antibody”

History and Milestone

  • 2011

    Incorporation

  • 2013
    -
    2014

    BIG-BIRAC
    (~ 5 Million INR)

  • 2015

    Indo-French CEFIPRA
    (~1 Million)

  • 2016

    Recombinant Antibody Platform Developed Range of Products

  • 2017

    Two Patents from Development

  • 2018

    WiNER Award
    (~0.5 Million INR)

  • 2018

    Technology Hotspot Award at Select Bio

  • 2019

    BIRAC-PACE Grant
    (~ 5 Million INR)

  • 2019

    ISO 9001: 2015 Quality Management Certification

  • National Biopharma Mission
    (~ 10 Million INR)

  • DSIR Accredition MoST, GOI

  • Samriddhi Grant

Biopharma Drug Discovery & Antibody engineering services

About Us

Established in 2011, Genext Genomics Pvt Ltd is an emerging life science research start up and contract research organization in central india, with focus on providing purpose-based solution for life science customers, a one stop solution for all your protein needs! Founded and managed by a team of scientists with extensive experience in both academia and industry, GNG is working for development of recombinant proteins and monoclonal antibodies against clinically relevant targets through the integration of bioinformatics, recombinant DNA technology, proteomics and immunology using novel high-throughput technologies.

GeNext Genomics offers a wide range of services that complement your research and accelerate the process from development to clinical use.

Our Services

ANTIBODY LIBRARY SERVICES

GeNext Genomics has proprietary phage display library for production of high affinity monoclonal antibodies and has been specialized in applying the technologies for wide range of service project.

 

Read More

 

 

 

 

RECOMBINANT PROTEINS EXPRESSION AND PURIFICATION

Cloning the gene, Sub cloning in the expression vector, Upstream- expression and purification at analytical scale; downstream process – scale up

 

Read More

 

 

 

MONOCLONAL ANTIBODIES PRODUCTION

Immunization of antigen, fusion, Production of hybridoma, Single cell cloning, Mab production

 

Read More

 

 

 

RECOMBINANT ANTIBODY SERVICES

Cloning scfv in E.Coli expression vector, Cloning of full IgG in CHO expression system

 

Read More

 

 

Contact us and receive a quote within 24 hours

Our Latest News Updates

Antibody Engineering Services: An Overview
April 21, 2023
Antibody Engineering Services: An Overview

Antibodies are an essential immune system component B-cells produce to neutralize pathogens such as bacteria, viruses,[…]

Scope of Monoclonal Antibody Drugs
April 19, 2023
Scope of Monoclonal Antibody Drugs

Introduction Monoclonal Antibody Drugs are a type of biological therapy that has revolutionized the treatment of[…]

4 Major Problems in Process Development for Recombinant Proteins
March 17, 2023
4 Major Problems in Process Development for Recombinant Proteins

Process development is not a top priority for many biotech businesses, especially those creating medications for[…]

[/et_pb_text][/et_pb_column][/et_pb_row][/et_pb_section]